Ftse Mib
35.390,52
-0,06%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.747,30
2,30%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Recro Pharma Inc (REPH) Recro Pharma Inc (REPH) Notizie

REPH

Recro Pharma (REPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:REPH
DataOraFonteTitoloSimboloCompagnia
06/06/202322:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
02/06/202322:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
26/05/202322:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
22/05/202323:11Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:REPHRecro Pharma Inc
06/04/202314:26Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REPHRecro Pharma Inc
24/03/202321:07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:REPHRecro Pharma Inc
01/03/202323:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
01/03/202322:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:REPHRecro Pharma Inc
16/12/202223:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:REPHRecro Pharma Inc
13/12/202223:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:REPHRecro Pharma Inc
09/11/202222:30Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REPHRecro Pharma Inc
07/09/202201:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:REPHRecro Pharma Inc
05/07/202222:37Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:REPHRecro Pharma Inc
27/06/202223:22Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:REPHRecro Pharma Inc
01/06/202223:06Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)NASDAQ:REPHRecro Pharma Inc
20/04/202223:45Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:REPHRecro Pharma Inc
04/04/202212:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:REPHRecro Pharma Inc
21/03/202212:00GlobeNewswire Inc.Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and TransformationNASDAQ:REPHRecro Pharma Inc
01/03/202222:05GlobeNewswire Inc.Recro Reports Fourth Quarter and Year End 2021 Financial ResultsNASDAQ:REPHRecro Pharma Inc
23/02/202213:00GlobeNewswire Inc.Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego FacilityNASDAQ:REPHRecro Pharma Inc
22/02/202222:05GlobeNewswire Inc.Recro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022NASDAQ:REPHRecro Pharma Inc
14/02/202222:36Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:REPHRecro Pharma Inc
11/02/202212:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:REPHRecro Pharma Inc
26/01/202213:00GlobeNewswire Inc.Recro Wins $1.5 Million Formulation Development and CGMP Manufacturing Contract to Support Clinical Development of Topical Treatment for Skin Cancer PreventionNASDAQ:REPHRecro Pharma Inc
19/01/202213:00GlobeNewswire Inc.Recro Appoints Eduardo Uribe as Head of Quality for Recro San DiegoNASDAQ:REPHRecro Pharma Inc
18/01/202213:20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:REPHRecro Pharma Inc
14/01/202223:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:REPHRecro Pharma Inc
06/01/202222:05GlobeNewswire Inc.Recro Reports Inducement Grants For New StaffNASDAQ:REPHRecro Pharma Inc
03/01/202213:00GlobeNewswire Inc.Recro to Present at H.C. Wainwright BioConnect 2022 ConferenceNASDAQ:REPHRecro Pharma Inc
02/12/202113:00GlobeNewswire Inc.Recro to Present at Stephens Annual Investment ConferenceNASDAQ:REPHRecro Pharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:REPH

La tua Cronologia

AMEX
YXI
ProShares Short FTSE Chi...
TG
SWI
Swire Pac A
EU
S499S
S499S
AQSE
AFRN.GB
Aferian
ASX
ACX
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network